GL1X · GenesisL1 explorer

Research workbench

Crystal structure of fyn kinase domain complexed with staurosporine

Analyse Crystal structure of fyn kinase domain complexed with staurosporine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2DQ7
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase fyn
EC
2.7.10.2
UniProt
P06241
Ligands
STU
Pockets
1 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XProto-oncogene tyrosine-protein kinase fyn (EC 2.7.10.2)protein26335% helix, 19% strandP06241

Ligands and binding sites

  • STU · Staurosporine · ligand · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13850.670.8045STU

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 2DQ7 · Crystal Structure of Fyn kinase domain complexed with staurosporine · the same entry in another collection · chain X against X, TM-score 1.00
  • P06241 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase fyn (P06241) · a predicted model of the same protein · chain X against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.